{
    "id": "dbpedia_6044_1",
    "rank": 45,
    "data": {
        "url": "https://www.business-standard.com/article/current-affairs/china-approves-sinopharm-s-new-coronavirus-vaccine-for-clinical-trials-121041100291_1.html",
        "read_more_link": "",
        "language": "en",
        "title": "China approves Sinopharm's new coronavirus vaccine for clinical trials",
        "top_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-04/07/full/1617765583-8759.jpg",
        "meta_img": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-04/07/full/1617765583-8759.jpg",
        "images": [
            "https://sb.scorecardresearch.com/p?c1=2&c2=8021726&cv=4.4.0&cj=1",
            "https://bsmedia.business-standard.com/include/_mod/site/html5/images/business-standard-logo.png",
            "https://www.business-standard.com/assets/web-assets/images/logo-bs.webp",
            "https://bsmedia.business-standard.com/_media/bs/img/article/2021-04/07/full/1617765583-8759.jpg?im=FeatureCrop,size=(826,465)",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/icons/LinkedIN.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "COVID-19 vaccines",
            "Clinical trials",
            "Medicine",
            "Health sciences",
            "COVID-19 vaccine",
            "Medical research",
            "Medical specialties",
            "China National Pharmaceutical Group",
            "Vaccine",
            "Johnson & Johnson COVID-19 vaccine",
            "Aircraft Parts Manufacturing",
            "Advertising & Marketing (NEC)",
            "Pharmaceuticals (NEC)",
            "Weibo",
            "National Medical Products Administration",
            "National Health Commission",
            "bioscience subsidiary",
            "genetic engineering",
            "China",
            "SERUM INSTITUTE",
            "China National Biotec Group",
            "Wuhan Institute of Biological Products",
            "Xinhua",
            "Beijing Biological Products Institute",
            "recombinant vaccine technology",
            "antibodies",
            "National Vaccine & Serum Institute",
            "Serum Institute",
            "Sinopharm"
        ],
        "tags": null,
        "authors": [
            "Business Standard"
        ],
        "publish_date": "2021-04-11T13:50:00+05:30",
        "summary": "",
        "meta_description": "A new Covid-19 vaccine developed by China's Sinopharm has recently been approved for clinical trials.",
        "meta_lang": "en",
        "meta_favicon": "https://www.business-standard.com/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://www.business-standard.com/article/current-affairs/china-approves-sinopharm-s-new-coronavirus-vaccine-for-clinical-trials-121041100291_1.html",
        "text": "(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)"
    }
}